Literature DB >> 12198614

Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation.

Hakim Echchannaoui1, Karl Frei, Christian Schnell, Stephen L Leib, Werner Zimmerli, Regine Landmann.   

Abstract

Toll-like receptor-2 (TLR2) mediates host responses to gram-positive bacterial wall components. TLR2 function was investigated in a murine Streptococcus pneumoniae meningitis model in wild-type (wt) and TLR2-deficient (TLR2(-/-)) mice. TLR2(-/-) mice showed earlier time of death than wt mice (P<.02). Plasma interleukin-6 levels and bacterial numbers in blood and peripheral organs were similar for both strains. With ceftriaxone therapy, none of the wt but 27% of the TLR2(-/-) mice died (P<.04). Beyond 3 hours after infection, TLR2(-/-) mice had higher bacterial loads in brain than did wt mice, as assessed with luciferase-tagged S. pneumoniae by means of a Xenogen-CCD (charge-coupled device) camera. After 24 h, tumor necrosis factor activity was higher in cerebrospinal fluid of TLR2(-/-) than wt mice (P<.05) and was related to increased blood-brain barrier permeability (Evans blue staining, P<.02). In conclusion, the lack of TLR2 was associated with earlier death from meningitis, which was not due to sepsis but to reduced brain bacterial clearing, followed by increased intrathecal inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198614     DOI: 10.1086/342845

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  103 in total

Review 1.  Acute bacterial meningitis: time for a better outcome.

Authors:  Werner Zimmerli
Journal:  Intensive Care Med       Date:  2003-11       Impact factor: 17.440

Review 2.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

Review 5.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

6.  Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.

Authors:  Raymond Hong; Sudhanshu Agrawal; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 7.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

8.  Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Authors:  Abdul Q Khan; Quanyi Chen; Zheng-Qi Wu; James C Paton; Clifford M Snapper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

9.  Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.

Authors:  Manuela Puliti; Satoshi Uematsu; Shizuo Akira; Francesco Bistoni; Luciana Tissi
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.